Choroidal metastasis from non-small-cell lung cancer responsive to Osimertinib: a case reportEfficacy of a third-generation epidermal growth factor tyrosine kinase inhibitor

被引：0
|
作者：
Morara Mariachiara
Ruatta Celeste
Foschi Federico
Balducci Nicole
Ciardella Antonio
机构：
[1] University of Bologna,Ophthalmology Unit, S. Orsola
[2] University of Bologna,Malpighi Hospital
来源：
International Ophthalmology | 2018年 / 38卷
关键词：
Osimertinib; Choroidal metastasis; Carcinoma; Non-small-cell lung; Receptor; Epidermal growth factor; Tyrosine kinase inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2669 / 2675
页数：6
相关论文
共 50 条
  • [1] Choroidal metastasis from non-small-cell lung cancer responsive to Osimertinib: a case report: Efficacy of a third-generation epidermal growth factor tyrosine kinase inhibitor
    Mariachiara, Morara
    Celeste, Ruatta
    Federico, Foschi
    Nicole, Balducci
    Antonio, Ciardella
    INTERNATIONAL OPHTHALMOLOGY, 2018, 38 (06) : 2669 - 2675
  • [2] EFFICACY OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR IN TREATING CHOROIDAL METASTASIS FROM NON-SMALL-CELL LUNG CANCER
    Chee, Arnold S. H.
    Mak, Andrew C. Y.
    Kam, Ka Wai
    Li, Molly S. C.
    Ho, Mary
    Brelen, Marten E.
    Chen, Li Jia
    Yip, Wilson W. K.
    Young, Alvin L.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2025, 45 (02): : 207 - 214
  • [3] Overcoming resistance to third-generation epidermal growth factor receptor tyrosine kinase inhibitor in non-small cell lung cancer
    Noda-Narita, Shoko
    Kanda, Shintaro
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S187 - S190
  • [4] Third-generation epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
    Wright, Natalie M. Andrews
    Goss, Glenwood D.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S247 - S264
  • [5] Third-Generation Tyrosine Kinase inhibitors Targeting epidermal Growth Factor Receptor Mutations in non-Small Cell Lung Cancer
    Barnes, Tristan A.
    O'Kane, Grainne M.
    Vincent, Mark David
    Leighl, Natasha B.
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [6] Osimertinib: A third-generation tyrosine kinase inhibitor for treatment of epidermal growth factor receptor-mutated non-small cell lung cancer with the acquired Thr790Met mutation
    Bollinger, Meredith K.
    Agnew, Amanda S.
    Mascara, Gerard P.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (05) : 379 - 388
  • [7] Three Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: Similarities and Differences
    Chen, Ling
    Zhou, Yangqingqing
    Gan, Chaosheng
    Wang, XiaoLi
    Liu, Yihui
    Dong, Chunhui
    He, Ruiyuan
    Yang, Jin
    CANCER INVESTIGATION, 2022, 40 (07) : 590 - 603
  • [8] Third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer
    Pirker, Robert
    CURRENT OPINION IN ONCOLOGY, 2016, 28 (02) : 115 - 121
  • [9] Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non-Small Cell Lung Cancer Patients
    Yang, Zhe
    Yang, Nong
    Ou, Qiuxiang
    Xiang, Yi
    Jiang, Tao
    Wu, Xue
    Bao, Hua
    Tong, Xiaoling
    Wang, Xiaonan
    Shao, Yang W.
    Liu, Yunpeng
    Wang, Yan
    Zhou, Caicun
    CLINICAL CANCER RESEARCH, 2018, 24 (13) : 3097 - 3107
  • [10] Epidermal growth factor receptor tyrosine kinase inhibitor in treatment of brain metastasis from non-small cell lung cancer
    Zhang, Lan-jun
    Cai, Ling
    Zhu, Jian-fei
    Rong, Tie-hua
    Wu, Shao-xiong
    Chen, Zhong-pin
    Liu, Meng-zhong
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345